Sign in
4

Changes in Ownership

Adaptimmune Therapeutics PLC Filed Acc 0001104659-20-004423

Chief Operating Officer sold 2,397 shares at $5.13 ($12,308)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Bertrand William C JR Chief Operating Officer 2020-01-14 Sale −2,397 $5.13 $12,308 3,605 D
Open-market sales · 2,397 sh · avg $5.13 · $12,308
Loading xslF345X03/a4.xml…